Mitigation Study Period definition

Mitigation Study Period means the duration of time extending six consecutive Capability Periods and beginning with the Starting Capability Period associated with a Class Year Study, Additional SDU Study, and/or Expedited Deliverability Study. For purposes of Section 23.4.5 of this Attachment H, “Mitigated UCAP” shall mean one or more megawatts of Unforced Capacity that are subject to Control by a Market Party that has been identified by the ISO as a Pivotal Supplier. For purposes of Section 23.4.5 of this Attachment H, “Mitigation Net CONE” shall mean the capacity price on the currently effective ICAP Demand Curve for the Mitigated Capacity Zone corresponding to the average amount of excess capacity above the Mitigated Capacity Zone Installed Capacity requirement, expressed as a percentage of that requirement, that formed the basis for the ICAP Demand Curve approved by the Commission.
Sample 1Sample 2Sample 3
Mitigation Study Period means the duration of time extending six consecutive Capability Periods and beginning with the Starting Capability Period associated with a Class Year Study, Additional SDU Study, and/or Expedited Deliverability Study.
Sample 1Sample 2Sample 3
Mitigation Study Period means the six Capability Periods beginning with the Starting Capability Period. [NYISO Note: The NYISO’s Oct. 24] presentation proposed to delete the defined term “NCZ Examined Project”. The NYISO is now proposing to retain it with the following proposed revisions.]
Sample 1

Examples of Mitigation Study Period in a sentence

  • For purposes of Section 23.4.5.7.4, the inflation index shall mean the average of the most recently published median Headline Consumer Price Index (CPI) and Headline Personal Consumption Expenditures (PCE) long-term annual averages for inflation over the ten years that includes the last year of the Mitigation Study Period, as reported by the Survey of Professional Forecasters, unless this index is eliminated, replaced or otherwise terminated by the publisher thereof.

  • The amount of CRIS MW in a given study that has received a Renewable Exemption will be subtracted from the total amount of MW available for Renewable Exemptions so that only the remainder will be available to Examined Facilities and NCZ Examined Projects in subsequent studies that use the same Mitigation Study Period.

  • After the 1,000 MW of Renewable Exemption available in a given Mitigation Study Period has been exhausted no Renewable Exemptions will be available to Renewable Exemption Applicants in a subsequent Class Year Study, Deliverability Study, or Expedited Deliverability Study using the same Mitigation Study Period.

  • If the number of CRIS MW associated with multiple Renewable Exemption Applicants in a given Class Year Study, Additional SDU Study or Expedited Deliverability Study would exhaust the total amount of MW available for Renewable Exemptions in a given Mitigation Study Period then the ISO would allocate the total amount of remaining MW pro rata based upon the CRIS MW requested by each Renewable Exemption Applicant in that study that accepts its CRIS MW.

  • The Unit Net CONE reflects the long term inflation rate of 2.15% That rate is a long term inflation rate of 2.4 net of 0.25% for technological progress.In order to perform the Unit Net CONE analysis, the NYISO first expresses the project’s costs in the year’s dollars of the first year of the Mitigation Study Period.

  • The problems encountered and their severity and impact is a familiar story to many different projects, as the only application not requiring any cleanup is co-firing, particularly in a waste-to-energy plant (Augenstein and Pacey, 1992).Monitoring and cleanup may be expensive, but corroded boiler tubes and seized engines can be costlier still in terms of downtime, lost revenues, equipment repair and replacement, and ultimately, cleanup system retrofit.

  • It does so by inflating the Unit Net Cone for years two and three of the Mitigation Study Period, and then takes a straight average of those three values.

  • The youth worker supports disengaged students in their social and emotional wellbeing, encouraging their continued connection with school through provision of case management services and access to accredited flexible learning.

  • The overall intention is to complete the paving of the different classes of roads in a phased manner.

  • To account for this, the prong (a) Default exemption test provisions require NYISO to make a reasonable projection of what the demand curve prices will be during the future Default Mitigation Study Period.

Related to Mitigation Study Period

  • Study Period means the period commencing at 9:00 a.m. on the date hereof, and continuing through 5:00 p.m. on the Closing Date.

  • Feasibility Study means the evaluation and analysis of the potential of a project, which aims at supporting the process of decision-making by objectively and rationally uncovering its strengths and weaknesses, opportunities and threats, as well as identifying the resources required to carry it through and ultimately its prospects for success;

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Phase 1 Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of Licensed Product or that would otherwise satisfy the requirements of 21 C.F.R. 312.21(a) or an equivalent clinical trial in a country in the Territory other than the United States.

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Clinical Studies means Xxxxx 0, Xxxxx 0, Xxxxx 0, Xxxxx 3, and such other tests and studies in human subjects that are required by Applicable Law, or otherwise recommended by the Regulatory Authorities, to obtain or maintain Regulatory Approvals for a Licensed Product for one (1) or more indications, including tests or studies that are intended to expand the Product Labeling for such Licensed Product with respect to such indication.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.